Connecticut’s recently created Bioscience Innovation Fund has awarded nearly $2 million to UConn and Yale startups, as well as two researchers from those schools.
Storrs’ Dura Biotech and Hamden’s CaroGen Corp. received $500,000 and $400,368, respectively. Dura is developing a valve for transcatheter aortic valve replacements, while CaroGen is developing a hepatitis B vaccination.
Meanwhile, Dr. Demetrios Braddock of Yale and Dr. Quing Zhu of UConn each received $500,000.
Braddock is studying a novel therapeutic for treatment of a fatal orphan disease, while Zhu is developing a handheld imager that would supplement ultrasound systems for breast imaging.
Connecticut Innovations manages the $200 million fund, which was created in 2013.
Read more
Five CT tech startups draw $800K
Industry heavyweights named as overseers of $200M fund
